Financials
- Market Capitalization 13.51 M
- Employee 29
- Founded 2011
- CEO N/A
- Website www.renovarogroup.com
- Headquarter Delaware, United States
- FIGI BBG0060CNMG8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.01
ratio cours/chiffre d'affaires
-2.58
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4720 | PASG Passage Bio, Inc. - Common Stock | 4.44 USD | -0.45% | -9.76% | -21.69% | -49.77% | 14.24 M USD | ||
| 4729 | INAB IN8bio, Inc. - Common Stock | 1.38 USD | +2.99% | -1.43% | -4.83% | -17.37% | 13.59 M USD | ||
| 4735 | GTBP GT Biopharma, Inc. - Common Stock | 0.37 USD | -5.13% | -17.78% | -22.92% | -81.86% | 13.34 M USD | ||
| 4736 | BLRX BioLineRx Ltd - American Depositary Shares | 3.05 USD | -1.61% | +9.32% | -4.69% | +8.54% | 13.27 M USD |